PIK3CA and laryngeal carcinoma: In contrast, lesions harboring PIK3CA gene amplification exhibited a significantly higher laryngeal cancer risk than negative lesions (Figure 3C, Log-rank test, p = 0.019; HR = 2.74, 95% CI 1.13–6.63, Cox regression p = 0.025).